Clinician In-Residence

Dognosis; Bangalore Rural; On-site; INR 1,800,000 - 3,200,000; Full time

Benefits offered by this job

Co-authorship opportunities

Collaborative team culture

Job summary

Dognosis in Bangalore, India is hiring a Clinician In-Residence to be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world. This cross-functional role spans product, clinical ops, medical affairs, regulatory, and research.

You will be embedded across teams to shape protocols today and build a medical foundation for a consumer screening product tomorrow.

Qualifications

• MBBS with registration to practice in India, ideally Karnataka.
• Strong communication skills with patients and clinicians.
• Interest in product development and diagnostics.
• Ability to operate in unstructured, cross-functional environments.
• Interest in research and novel care pathways.

Responsibilities

• Shape study protocols and clinical workflows with the team.
• Design user experience for breath-based product and patient journey.
• Develop counselling workflow for BreathEasy users and medical contacts.
• Contribute to research publications and represent the company at conferences.

Skills

Strong communication

Product development interest

Cross-functional collaboration

Education

MBBS with registration in India (Karnataka ideal)

Job description

Bangalore North, India

Dognosis digitizes canine cognition to detect 30+ human cancers from a single breath sample, with accuracy exceeding standard-of-care diagnostics and at a cost low enough to scale across entire populations.

We're backed by top-tier VCs across India, the US, Israel, and Europe (including Accel India) and have published in the Journal of Clinical Oncology (#1 journal in oncology). We collaborate with UCL, Narayana Health, and Medical Detection Dogs, and have been covered by Scientific American, New Scientist, and Deccan Herald.

Job Description

As our Clinician In-Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world.

About the Role

This is a cross-functional medical role, involving work across product, clinical operations, medical affairs, regulatory, patient experience, and research. Dognosis runs a multi-site prospective clinical study under ICH-GCP and Indian GCP compliance, and is preparing for commercial rollout. You will be embedded across both: shaping protocols and ensuring scientific rigor today, and helping build the medical foundation for a consumer screening product tomorrow.

What You'll Do

• Shape study protocols and clinical workflows alongside the Clinical & Founding Team.
  
• Shape the user experience and customer journey for our breath-based product(s) for MCED (multi-cancer early detection) and recurrence monitoring.
  
• Build and iterate on the counselling workflow for BreathEasy users on their screening results and serve as the medical point of contact for patient-facing interactions.
  
• Contribute to research publications and represent Dognosis at scientific conferences.
  

What You Need

• MBBS with registration to practice in India, and ideally in Karnataka.
  
• Strong communication skills. You can explain complex medical concepts in simple terms to customers and the general public, while retaining strong clinical confidence with clinicians.
  
• Genuine interest in product development. You want to shape how diagnostics reach people.
  
• Comfort in unstructured environments where you define your own priorities and work across functions.
  
• Interest in research and figuring out novel care pathways.
  

Nice to have

• Experience in clinical research, whether during training, residency, or independently.
  
• Experience in public-facing community (blog, social media, educational content).
  

What You'll Get

• Potential co-authorship on research in top-tier journals. Dognosis has been published in the Journal of Clinical Oncology and presents frequently at ASCO, AACR, Cancer Research UK.
  
• Network and interactions with leading hospitals in India and the USA (Narayana Health, KMCRI, Tata Memorial, Harvard's Dana-Farber Cancer Institute) and globally renowned researchers.
  
• Competitive salary and matching perks at a company backed by Accel, Berkeley's The House Fund, and other leading global investors.
  
• Working with a high-touch interdisciplinary team spanning engineers, scientists, and working detection dogs. The office is never boring.
  
• Ownership over a novel product with potential for a paradigm-shift in oncology and how we detect and treat cancer.